TAS2940

Delivery:
oral
MOA:

Covalent pan-ERBB inhibitor with high potency against HER2/EGFR exon20 insertion

Indication:

Solid Tumours


Covalent pan-ERBB inhibitor with high potency against HER2/EGFR exon20 insertion

Phase 1 Study